Celgene Corporation to Present at the 31st Annual J.P. Morgan Healthcare Conference JPMorgan Healthcare Conference 2013 Business Wire SUMMIT, N.J. -- December 21, 2012 Celgene Corporation (NASDAQ: CELG) today announced its presentation at the 31^st Annual J.P. Morgan Healthcare Conference on January 7, 2013 at 11:00a.m. E.T. will be webcast live and will be available in the investor relations section of the company’s Web site at www.celgene.com. Celgene management will provide an overview of the company. About Celgene Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company’s Web site at www.celgene.com. Contact: Celgene Corporation Jacqualyn A. Fouse, Ph.D, 908-673-9956 EVP, Chief Financial Officer or Patrick E. Flanigan III, 908-673-9969 VP, Investor Relations
Celgene Corporation to Present at the 31st Annual J.P. Morgan Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.